- Investing Ideas
- Singaporean Pharmaceuticals & Biotech Insider-Bought Value Plays
Singaporean Pharmaceuticals & Biotech Insider-Bought Value Plays
Results
2
0 new
2 companies
Hyphens Pharma International
Market Cap: S$100.4m
Operates as a specialty pharmaceutical and consumer healthcare company primarily in Singapore, Vietnam, Malaysia, and internationally.
1J5
S$0.33
7D
1.6%
1Y
6.6%
Pharmesis International
Market Cap: S$11.4m
An investment holding company, research, develops, produces, packages, sells, and markets western medicines and traditional Chinese medicine (TCM) formulated products for hospitals and medical institutions in the People’s Republic of China.
BFK
S$0.36
7D
0%
1Y
n/a